DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-19.23%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$384M
AUM Growth
+$384M
(-3.5%)
Cap. Flow
+$76M
Cap. Flow
% of AUM
19.81%
Top 10 Holdings %
Top 10 Hldgs %
46.53%
Holding
98
New
11
Increased
36
Reduced
12
Closed
4
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$24.2M |
| 2 |
iShares Biotechnology ETF
IBB
|
$8.03M |
| 3 |
Fate Therapeutics
FATE
|
$4.99M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$4.77M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$3.51M |
Top Sells
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$11.1M |
| 2 |
OTIC
Otonomy, Inc.
OTIC
|
$1.69M |
| 3 |
HOOK
HOOKIPA Pharma
HOOK
|
$747K |
| 4 |
Xenon Pharmaceuticals
XENE
|
$688K |
| 5 |
ProQR Therapeutics
PRQR
|
$685K |
Sector Composition
| 1 | Healthcare | 86.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Arcus Biosciences
RCUS
$1.24B
| $4.58M | 1.19% |
145,217
+28,017
| +24% | +$884K |
|
27
Alector
ALEC
$282M
| $4.17M | 1.09% |
292,747
+137,500
| +89% | +$1.96M |
|
|
OTIC
28
DELISTED
Otonomy, Inc.
OTIC
| $3.59M | 0.94% |
1,497,514
-702,783
| -32% | -$1.69M |
|
29
Ascendis Pharma
ASND
$12.1B
| $3.59M | 0.94% |
30,612
+19,612
| +178% | +$2.3M |
|
|
MRTX
30
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.51M | 0.91% |
+42,700
| New | +$3.51M |
|
31
Edgewise Therapeutics
EWTX
$1.54B
| $3.46M | 0.9% |
+356,750
| New | +$3.46M |
|
32
Century Therapeutics
IPSC
$40.4M
| $3.23M | 0.84% |
256,892
+156,757
| +157% | +$1.97M |
|
33
Accuray
ARAY
$165M
| $3.12M | 0.81% |
941,800
| – | – |
|
|
PRDS
34
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $3.04M | 0.79% |
421,157
+187,657
| +80% | +$1.35M |
|
|
REUN
35
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
| $2.94M | 0.77% |
2,191,308
+1,850,408
| +543% | +$2.48M |
|
|
ITOS
36
DELISTED
iTeos Therapeutics
ITOS
| $2.87M | 0.75% |
89,298
+35,208
| +65% | +$1.13M |
|
37
KalVista Pharmaceuticals
KALV
$713M
| $2.81M | 0.73% |
190,663
| – | – |
|
38
Rigel Pharmaceuticals
RIGL
$710M
| $2.68M | 0.7% |
896,100
+17,100
| +2% | +$51.1K |
|
39
Galapagos
GLPG
$2.06B
| $2.65M | 0.69% |
42,675
| – | – |
|
40
Axogen
AXGN
$718M
| $2.64M | 0.69% |
332,103
| – | – |
|
|
AERI
41
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.63M | 0.69% |
289,040
| – | – |
|
|
AFMD
42
DELISTED
Affimed
AFMD
| $2.5M | 0.65% |
571,282
| – | – |
|
|
FSTX
43
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $2.46M | 0.64% |
693,785
| – | – |
|
|
BCYC
44
Bicycle Therapeutics
BCYC
$492M
| $2.33M | 0.61% |
+53,200
| New | +$2.33M |
|
45
Athira Pharma
ATHA
$15.5M
| $2.17M | 0.57% |
160,983
| – | – |
|
|
AUTL
46
Autolus Therapeutics
AUTL
$383M
| $2.07M | 0.54% |
+496,150
| New | +$2.07M |
|
|
SURF
47
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $2M | 0.52% |
680,000
+365,000
| +116% | +$1.07M |
|
48
Kura Oncology
KURA
$732M
| $1.82M | 0.47% |
113,329
+2,500
| +2% | +$40.2K |
|
|
DICE
49
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $1.8M | 0.47% |
+94,000
| New | +$1.8M |
|
|
BWAY
50
Brainsway
BWAY
$296M
| $1.75M | 0.46% |
200,000
| – | – |
|